| payload |
{"created_at":"2026-04-19T03:01:53.054 {"created_at":"2026-04-19T03:01:53.054716+00:00","dedupe_key":"signal_enriched:market_headline_delta:b5319eca6b58dc3f","evidence_event_ids":["evt_64e0fd07e473"],"signal_type":"market_headline_delta","source":"market_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5","as_of":"2026-04-19T03:01:53.054716+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_a7ec06664781411a","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-19T03:25:27.131837+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"ad-hoc-news.de","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5","source_event_id":"evt_64e0fd07e473","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"5344b176d08b8689","published_at":"2026-04-19T02:10:54+00:00","publisher_domain":"ad-hoc-news.de","signal_understanding":{"analysis_basis":"headline_only","claim_confidence":0.28,"dates_mentioned":[],"entities":[],"event_type":"price_action","information_gaps":["article_text_unavailable","source_summary_missing"],"key_facts":["Headline: Green Cross Corp (GC Biopharma) stock (KR7006280002): Why its plasma therapy focus now matters more - AD HOC NEWS"],"numeric_claims":[],"primary_claim":"Green Cross Corp (GC Biopharma) stock (KR7006280002): Why its plasma therapy focus now matters more - AD HOC NEWS","relevance_score":0.34,"sentiment":"neutral","source_quality":"unknown","summary":"Green Cross Corp (GC Biopharma) stock (KR7006280002): Why its plasma therapy focus now matters more - AD HOC NEWS","topics":["market headline"]},"source":"AD HOC NEWS","source_domain":"ad-hoc-news.de","source_url":"https://www.ad-hoc-news.de","summary":"","tickers":[],"title":"Green Cross Corp (GC Biopharma) stock (KR7006280002): Why its plasma therapy focus now matters more - AD HOC NEWS","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}}... |